Lighthouse Investment Partners’s AbbVie ABBV Stock Holding History

Lighthouse Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.58M	Buy	+10,270	New	+$2.21M	0.07%	318
2025 Q2	–	Sell	-5,000	Closed	-$1.05M	–	531
2025 Q1	$1.05M	Buy	+5,000	New	+$972K	0.04%	327
2024 Q4	–	Sell	-2,054	Closed	-$406K	–	472
2024 Q3	$406K	Buy	+2,054	New	+$383K	0.02%	387

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lighthouse Investment Partners's ABBV Position: Q2 2026 in Review

Lighthouse Investment Partners opened a new position in AbbVie (ABBV) in Q2 2026: 10,270 shares worth $2.58M. The stake represents 0.07% of the portfolio and ranks #318 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in ABBV as recently as Q1 2025.

Lighthouse Investment Partners first reported a position in ABBV in Q3 2024 and has held it in 3 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Lighthouse Investment Partners held 10,270 shares of AbbVie worth $2.58M as of Q2 2026.
AbbVie was a new Lighthouse Investment Partners position in Q2 2026.
AbbVie made up 0.07% of Lighthouse Investment Partners's portfolio in Q2 2026, its #318 holding.
Lighthouse Investment Partners first reported a position in AbbVie in Q3 2024 and has held it in 3 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.